内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

CVRx, Inc.

CVRX · Nasdaq · CIK 0001235912 · Healthcare · Medical Devices

内部人信号

44.3 / 100

1 位买方 · 1 条买入交易行 · $76.3K 买入总额

为什么有这个信号？

买方广度较低
买入规模较低
角色较强
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+6.4 / 25
角色+18.0 / 20
近期性+3.3 / 10
确信度+9.6 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Purchase activity is becoming less recent
  • ✓ 角色得分高 · 买入者中职位最高的是：CHIEF OPERATING OFFICER

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Binkowski BrentCHIEF OPERATING OFFICER
▼●
Nielsen Kirk G.Director
○
Jain Mudit K.Director
○
SLATTERY JOSEPH PDirector
○
Hill, Mitch C.Director
○
Ballinger Kevin J.Director
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方1
买入集中度100%最大买方： Binkowski Brent · $76.3K
聚集买入 · 15天1 insider峰值活动： 2026-08-13–2026-08-13

Roles in the peak window: CHIEF OPERATING OFFICER. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

44.3 / 100

最新留档分数

↓ -0.1 pts相对上一个留档快照
  1. 44.8
  2. 44.6
  3. 44.5
  4. 44.4
  5. 44.3

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

3买入
14卖出
14其他 Form 4 交易行
23SEC 申报 · 365天
买入1 qualifying P line(s) · 180 days
卖出1 sale line(s) · 仅供背景
其他7 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-44.8%
3M
-70.9%
6M
-77.9%
12M
-82.7%

波动率与流动性

波动率
102.7%
Beta
—
平均每日成交额
USD 1.5M

估值

市值
USD 42.1M
P/E
—

基本面

利润率
-94.1%
ROE
-135.6%
细分行业
Medical Devices

市场数据

价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-30 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
1,982,426
上期报告
1,643,732
日均成交量
826,036
回补天数
2.4

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-08-13Binkowski Brent买入 (P)Common Stock26,223USD 2.91USD 76,309SEC 申报 ↗
2026-02-20Jain Mudit K.买入 (P)Common Stock46,800USD 6.36USD 297,648SEC 申报 ↗
2026-02-18Jain Mudit K.买入 (P)Common Stock600USD 4.64USD 2,784SEC 申报 ↗
2025-05-15Nielsen Kirk G.买入 (P)Common Stock10,966USD 5.45USD 59,765SEC 申报 ↗
2025-05-14Nielsen Kirk G.买入 (P)Common Stock61,200USD 5.23USD 320,076SEC 申报 ↗
2025-05-13Nielsen Kirk G.买入 (P)Common Stock101,413USD 5.29USD 536,475SEC 申报 ↗
2025-05-13Jain Mudit K.买入 (P)Common Stock150USD 5.26USD 789SEC 申报 ↗
2025-05-12Nielsen Kirk G.买入 (P)Common Stock25,200USD 4.79USD 120,708SEC 申报 ↗
2025-05-12Jain Mudit K.买入 (P)Common Stock1,500USD 4.66USD 6,990SEC 申报 ↗
2025-05-12Hykes Kevin买入 (P)Common Stock5,000USD 4.84USD 24,200SEC 申报 ↗
2024-08-15SLATTERY JOSEPH P买入 (P)Common Stock3,000USD 8.10USD 24,300SEC 申报 ↗
2024-08-08SLATTERY JOSEPH P买入 (P)Common Stock3,000USD 8.24USD 24,720SEC 申报 ↗
2024-08-06SLATTERY JOSEPH P买入 (P)Common Stock2,500USD 9.09USD 22,725SEC 申报 ↗
2024-08-05Hykes Kevin买入 (P)Common Stock30,000USD 8.36USD 250,800SEC 申报 ↗
2022-05-24Nielsen Kirk G.买入 (P)Common Stock8,070USD 5.05USD 40,754SEC 申报 ↗

Form 4 申报证据

31 transaction lines in the latest 365-day window; 193 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-13Binkowski Brent买入 (P)Common Stock26,223USD 2.91USD 76,309SEC 申报 ↗
2026-08-12Binkowski Brent卖出 (S)Common Stock1,309USD 2.55USD 3,338SEC 申报 ↗
2026-06-01SLATTERY JOSEPH P奖励／授予 (A)Common Stock8,720USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-13Binkowski Brent买入 (P)Common Stock26,223USD 2.91USD 76,309SEC 申报 ↗
2026-08-12Binkowski Brent卖出 (S)Common Stock1,309USD 2.55USD 3,338SEC 申报 ↗
2026-06-01SLATTERY JOSEPH P奖励／授予 (A)Common Stock8,720USD 0.00USD 0SEC 申报 ↗
2026-06-01SHADAN MARTHA奖励／授予 (A)Common Stock8,720USD 0.00USD 0SEC 申报 ↗
2026-06-01Nielsen Kirk G.奖励／授予 (A)Common Stock8,720USD 0.00USD 0SEC 申报 ↗
2026-06-01Jain Mudit K.奖励／授予 (A)Common Stock8,720USD 0.00USD 0SEC 申报 ↗
2026-06-01Hill, Mitch C.奖励／授予 (A)Common Stock8,720USD 0.00USD 0SEC 申报 ↗
2026-06-01DALE MICHAEL D奖励／授予 (A)Common Stock29,005USD 0.00USD 0SEC 申报 ↗
2026-06-01Ballinger Kevin J.奖励／授予 (A)Common Stock8,720USD 0.00USD 0SEC 申报 ↗
2026-03-02Adamson Philip B.卖出 (S)Common Stock1,262USD 7.90USD 9,970SEC 申报 ↗
2026-03-02Morrison Gregory奖励／授予 (A)Common Stock34,000USD 0.00USD 0SEC 申报 ↗
2026-03-02VERRASTRO PAUL卖出 (S)Common Stock1,284USD 7.90USD 10,144SEC 申报 ↗
2026-03-02OASHEIM JARED卖出 (S)Common Stock1,744USD 7.90USD 13,778SEC 申报 ↗
2026-03-02John Robert Allen卖出 (S)Common Stock3,964USD 7.90USD 31,316SEC 申报 ↗
2026-03-02Hykes Kevin卖出 (S)Common Stock7,763USD 7.90USD 61,328SEC 申报 ↗
2026-02-27Adamson Philip B.奖励／授予 (A)Common Stock41,000USD 0.00USD 0SEC 申报 ↗
2026-02-27VERRASTRO PAUL奖励／授予 (A)Common Stock45,000USD 0.00USD 0SEC 申报 ↗
2026-02-27OASHEIM JARED奖励／授予 (A)Common Stock61,000USD 0.00USD 0SEC 申报 ↗
2026-02-27John Robert Allen奖励／授予 (A)Common Stock35,000USD 0.00USD 0SEC 申报 ↗
2026-02-27Hykes Kevin奖励／授予 (A)Common Stock159,000USD 0.00USD 0SEC 申报 ↗
2026-02-27Binkowski Brent奖励／授予 (A)Common Stock15,000USD 0.00USD 0SEC 申报 ↗
2026-02-20Jain Mudit K.买入 (P)Common Stock46,800USD 6.36USD 297,648SEC 申报 ↗
2026-02-18Jain Mudit K.买入 (P)Common Stock600USD 4.64USD 2,784SEC 申报 ↗
2025-11-26JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.卖出 (S)Common Stock6,337USD 10.03USD 63,560SEC 申报 ↗
2025-11-26JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.卖出 (S)Common Stock6,337USD 10.03USD 63,560SEC 申报 ↗
2025-11-25JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.卖出 (S)Common Stock16,000USD 10.03USD 160,480SEC 申报 ↗
2025-11-24JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.卖出 (S)Common Stock2,200USD 10.06USD 22,132SEC 申报 ↗
2025-11-21JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.卖出 (S)Common Stock500USD 10.00USD 5,000SEC 申报 ↗
2025-11-12JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.卖出 (S)Common Stock1,000USD 10.00USD 10,000SEC 申报 ↗
2025-11-07JOHNSON & JOHNSON; Johnson & Johnson Innovation - JJDC, Inc.卖出 (S)Common Stock200USD 10.00USD 2,000SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码CVRX
CIK0001235912
行业Healthcare
细分行业Medical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
交易所Nasdaq

数据覆盖

本地 Form 4 历史193 transaction lines from 2021-06-30 to 2026-08-13
41 P purchase lines · 21 S sale lines · 131 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.